C William Wester

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. pmc Effect modification by sex and baseline CD4+ cell count among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial
    C William Wester
    Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS Res Hum Retroviruses 28:981-8. 2012
  2. pmc Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial
    C William Wester
    Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS Res Hum Retroviruses 28:759-65. 2012
  3. pmc Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia
    John R Koethe
    Centre for Infectious Diseases Research in Zambia, Plot 1275 Lubuto Road, Lusaka, Zambia
    J Int AIDS Soc 14:19. 2011
  4. pmc Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program
    Hermann Bussmann
    Botswana Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education, Department of Immunology and Infectious Diseases, Boston, Massachusetts, USA
    AIDS 22:2303-11. 2008
  5. pmc Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial
    Bethan McDonald
    Harvard School of Public Health AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA
    AIDS Res Hum Retroviruses 29:993-9. 2013
  6. ncbi request reprint The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa
    Vlad Novitsky
    Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, 02115, USA
    AIDS Res Hum Retroviruses 23:868-78. 2007
  7. pmc HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission
    Vladimir Novitsky
    Harvard School of Public Health AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 5:e10148. 2010
  8. ncbi request reprint Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana
    Hermann Bussmann
    Harvard School of Public Health AIDS Initiative, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 45:269-73. 2007
  9. pmc Strengthening Healthcare Capacity Through a Responsive, Country-Specific, Training Standard: The KITSO AIDS Training Program's Sup-port of Botswana's National Antiretroviral Therapy Rollout
    Christine Bussmann
    Harvard School of Public Health, 651 Huntington Ave, Boston, MA 02115, USA
    Open AIDS J 2:10-6. 2008

Collaborators

Detail Information

Publications9

  1. pmc Effect modification by sex and baseline CD4+ cell count among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial
    C William Wester
    Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS Res Hum Retroviruses 28:981-8. 2012
    ..EFV-treated women and NVP-treated men had more favorable cART outcomes. In addition, adults initiating EFV-based cART at higher baseline CD4(+) cell count values had more favorable outcomes compared to those initiating NVP-based cART...
  2. pmc Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial
    C William Wester
    Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS Res Hum Retroviruses 28:759-65. 2012
    ..Women presently receiving d4T/3TC-based cART in such settings also warrant more intensive monitoring...
  3. pmc Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia
    John R Koethe
    Centre for Infectious Diseases Research in Zambia, Plot 1275 Lubuto Road, Lusaka, Zambia
    J Int AIDS Soc 14:19. 2011
    ..The relationship between nutrition and inflammation-related serum biomarkers and early treatment outcomes (e.g., less than 90 days) in this population is not well described...
  4. pmc Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program
    Hermann Bussmann
    Botswana Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education, Department of Immunology and Infectious Diseases, Boston, Massachusetts, USA
    AIDS 22:2303-11. 2008
    ..Antiretroviral treatment (ART) initiatives have now been established in many sub-Saharan African countries showing early benefits. To date, few results are available concerning long-term clinical outcomes in these treatment programs...
  5. pmc Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial
    Bethan McDonald
    Harvard School of Public Health AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA
    AIDS Res Hum Retroviruses 29:993-9. 2013
    ..Future translational studies are warranted to better elucidate pathophysiology and inform the design of novel interventions to ameliorate the risk of death among these "at-risk" individuals...
  6. ncbi request reprint The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa
    Vlad Novitsky
    Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, 02115, USA
    AIDS Res Hum Retroviruses 23:868-78. 2007
    ....
  7. pmc HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission
    Vladimir Novitsky
    Harvard School of Public Health AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 5:e10148. 2010
    ....
  8. ncbi request reprint Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana
    Hermann Bussmann
    Harvard School of Public Health AIDS Initiative, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 45:269-73. 2007
    ..Pregnancy rates are usually high in developing countries, and efavirenz (EFV) use in women of childbearing age is of concern because of its potential teratogenicity...
  9. pmc Strengthening Healthcare Capacity Through a Responsive, Country-Specific, Training Standard: The KITSO AIDS Training Program's Sup-port of Botswana's National Antiretroviral Therapy Rollout
    Christine Bussmann
    Harvard School of Public Health, 651 Huntington Ave, Boston, MA 02115, USA
    Open AIDS J 2:10-6. 2008
    ..Continuous and standardized clinical education will be crucial to sustain the present level of care and successfully address future treatment challenges...